Gianfranco Delle Fave
Sapienza University of Rome
CancerInternal medicineRadiologyEndocrinologySurgeryPathologyOncologyImmunologyPancreatitisGastritisPancreasNeuroendocrine tumorsDiseasePancreatic cancerIn patientEndocrine systemCancer researchMedicineBiologyGastroenterology
213Publications
50H-index
5,653Citations
Publications 211
Newest
#1Gabriele CapursoH-Index: 56
#2Sébastien Gaujoux (Paris V: Paris Descartes University)H-Index: 42
Last. Philippe Ruszniewski (Beaujon Hospital)H-Index: 3
view all 14 authors...
Abstract Background Factors associated with rectal NENs prognosis are poorly investigated. Aim To evaluate the prognostic role of the ENETs staging and grading systems in rectal NENs. Methods Tertiary referral, multicenter, retrospective study. Factors associated with OS and PFS were investigated by Cox-regression analysis, with best size cut-offs calculated by ROC analysis. Results Of 100 patients (mean age 55, 45% male, mean size 16.2 mm) 62, 5, 10 and 23 were TNM stage 1 to 4, and 63, 15 and ...
2 CitationsSource
#1Maria Lia ScribanoH-Index: 22
#2Flavio Caprioli (University of Milan)H-Index: 36
Last. Ambrogio OrlandoH-Index: 35
view all 21 authors...
Abstract The MARS-5 (Medication Adherence Report Scale) was developed in English. The aim of this project was to analyse the MARS-5I (© Prof Rob Horne) psychometric properties and to identify whether its Italian translation is suitable for assessing medication adherence in Crohn Disease (CD) Italian patients. The MARS was translated and linguistically validated in Italian. The MARS-5I was used for evaluating medication adherence in the SOLE study, conducted in Italy on 552 subjects with CD. In o...
5 CitationsSource
#1Daniele Campa (UniPi: University of Pisa)H-Index: 34
#2M Matarazzi (DKFZ: German Cancer Research Center)H-Index: 2
Last. Federico Canzian (DKFZ: German Cancer Research Center)H-Index: 82
view all 52 authors...
Telomere deregulation is a hallmark of cancer. Telomere length measured in lymphocytes (LTL) has been shown to be a risk marker for several cancers. For pancreatic ductal adenocarcinoma (PDAC) consensus is lacking whether risk is associated with long or short telomeres. Mendelian randomization approaches have shown that a score built from SNPs associated with LTL could be used as a robust risk marker. We explored this approach in a large scale study within the PANcreatic Disease ReseArch (PANDoR...
13 CitationsSource
#1Sara PuscedduH-Index: 18
#2Claudio VernieriH-Index: 17
Last. Filippo de Braud (University of Milan)H-Index: 69
view all 52 authors...
Abstract Background & Aims Metformin seems to have anti-cancer effects. However, it is not clear whether use of glycemia and metformin affect outcomes of patients with advanced pancreatic neuroendocrine tumors (pNETs). We investigated the association between glycemia and progression-free survival (PFS) of patients with NETs treated with everolimus and/or somatostatin analogues, as well as the association between metformin use and PFS time. Methods We performed a retrospective analysis of 445 pat...
24 CitationsSource
Source
Source
#1Caterina StornelloH-Index: 2
#2Livia ArchibugiH-Index: 13
Last. Gabriele CapursoH-Index: 56
view all 9 authors...
Source
#1Serena StiglianoH-Index: 11
#2Livia ArchibugiH-Index: 13
Last. Gabriele CapursoH-Index: 56
view all 6 authors...
Source
#1Ilaria Passacantilli (University of Rome Tor Vergata)H-Index: 5
#2Valentina PanzeriH-Index: 5
Last. Gabriele CapursoH-Index: 56
view all 6 authors...
: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer and current treatments exert small effects on life expectancy. The most common adjuvant treatment for PDAC is gemcitabine. However, relapse almost invariably occurs and most patients develop metastatic, incurable disease. The aim of the present study was to assess the activity of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) alone or in combination with gemcitabine in PDAC cell lines displaying different degrees of ...
2 CitationsSource
#1Maria Rinzivillo (Sapienza University of Rome)H-Index: 14
#2Stefano PartelliH-Index: 43
Last. Francesco Panzuto (Sapienza University of Rome)H-Index: 27
view all 14 authors...
Background. The role of F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG PET) in the diagnostic algorithm of entero-pancreatic neuroendocrine neoplasms (EP NENs) is unclear because most available data derive from heterogeneous populations in terms of tumor biology and disease status at time of examination. The aim of this study was to determine the ability of F-18-FDG PET to identify patients with more aggressive disease among those with advanced EP NENs.Subjects, Materials, and Me...
20 CitationsSource